Realseq
1 known investors
RealSeq develops the RiboMarker RNA biomarker discovery platform, combining library construction, next-generation sequencing, and AI bioinformatics to analyze RNA fragments for diagnostic applications such as liquid biopsies in oncology and infectious disease. The company also sells small RNA library preparation kits and sequencing services for research and industry partners.
AI & Machine LearningBiotechMedical Devices
Investors · 1
Frequently asked questions
- What does Realseq do?
- RealSeq develops the RiboMarker RNA biomarker discovery platform, combining library construction, next-generation sequencing, and AI bioinformatics to analyze RNA fragments for diagnostic applications such as liquid biopsies in oncology and infectious disease. The company also sells small RNA library preparation kits and sequencing services for research and industry partners.
- Who are Realseq's investors?
- Realseq's investors include Santa Cruz Venture.